Osimertinib-induced rapid regression of large metastatic tumor to the pituitary in a patient with lung adenocarcinoma

BACKGROUND: Metastatic nonsmall cell lung cancer (NSCLC) to the pituitary (NSCLC-PitM) is rare and often presents with visual field deficits. Surgical resection for the decompression of the optic apparatus has been the treatment of choice in such cases. Osimertinib is a third-generation tyrosine kin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Andrew K., Close, Troy W., Wong, Ricky H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827509/
https://www.ncbi.nlm.nih.gov/pubmed/33500828
http://dx.doi.org/10.25259/SNI_629_2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827509/
https://www.ncbi.nlm.nih.gov/pubmed/33500828
http://dx.doi.org/10.25259/SNI_629_2020

Ejemplares similares